APA (7th ed.) Citation

Y, L., C, Q., C, M., R, M., P, Z., B, Z., . . . X, Z. (2026). Hexokinase 2 upregulation is associated with glycolytic reprogramming and neuroinflammation in hypoxic-ischemic brain damage: A therapeutic target for early intervention. Frontiers in immunology, 17, 1837728. https://doi.org/10.3389/fimmu.2026.1837728

Chicago Style (17th ed.) Citation

Y, Li, Qin C, Miao C, Mu R, Zhang P, Zhang B, Zhao X, and Zhang X. "Hexokinase 2 Upregulation Is Associated with Glycolytic Reprogramming and Neuroinflammation in Hypoxic-ischemic Brain Damage: A Therapeutic Target for Early Intervention." Frontiers in Immunology 17 (2026): 1837728. https://doi.org/10.3389/fimmu.2026.1837728.

MLA (9th ed.) Citation

Y, Li, et al. "Hexokinase 2 Upregulation Is Associated with Glycolytic Reprogramming and Neuroinflammation in Hypoxic-ischemic Brain Damage: A Therapeutic Target for Early Intervention." Frontiers in Immunology, vol. 17, 2026, p. 1837728, https://doi.org/10.3389/fimmu.2026.1837728.